Mayne Pharma Group Limited has launched doxycycline monohydrate for immediate release (IR) capsules (50mg, 75mg, and 100mg) in the United States. Doxycycline IR capsules are a generic alternative to Monodox, a tetracycline-class antibacterial indicated for the treatment of a number of infections, including adjunctive therapy in severe acne. Mayne Pharma’s CEO Scott Richards said, “This…